About
Platform
Therapeutics
Partnering
Careers
Newsroom
Publications
Contact
X
LinkedIn
Contact Us

The Latest

Newsroom

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Recent Posts

4/28/2026
Behind the scenes: the platform connecting designs to data at scale
Announcements
3/12/2026
How to Get the Most out of Your Protein Language Model for Antibody Drug Design
Blog
3/5/2026
Behind the scenes: the automation underneath BigHat’s in-house CFPS manufacturing
Announcements
1/7/2026
BigHat Biosciences Partners with Lilly to Advance Machine Learning–Enabled Biologics Discovery Through Lilly TuneLab
Press
10/28/2025
BigHat Announces Successful Completion of Our Strategic Collaboration with Johnson & Johnson
Announcements
9/30/2025
Introducing Reccy Antibody Design Studio (RADS)
Announcements
4/17/2025
BigHat Biosciences and Lilly Collaborate to Advance AI-Driven Antibody Therapeutics
Press
3/4/2025
BigHat’s Next Chapter: A Message from CEO Peyton Greenside
Announcements
11/4/2024
Lonza’s Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC
Press
8/13/2024
BigHat featured on Genetic Engineering & Biotechnology News
Announcements
8/5/2024
BigHat named to the 2024’s Fierce Biotech 15
Announcements
6/27/2024
BigHat’s Cofounder and CSO, Peyton Greenside, Joins the Timmerman Traverse for Sickle Forward
Announcements
Contact
1900 Alameda de las Pulgas
Suite 400
San Mateo, CA 94403
Navigation
About
Platform
Therapeutics
Partnering
Careers
Newsroom
Publications
Social
X
LinkedIn
© BigHat Bio 2026